4//SEC Filing
Saad Kareem 4
Accession 0001209191-24-000376
CIK 0001818331other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:25 PM ET
Size
7.6 KB
Accession
0001209191-24-000376
Insider Transaction Report
Form 4
Saad Kareem
Chief Business Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2024-01-01−273→ 2,455 total→ Class A Common Stock (273 underlying) - Exercise/Conversion
Class A Common Stock
2024-01-01+273→ 24,219 total
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- [F2]6.25% vest in quarterly installments over the 4-year period on April 4, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date
Documents
Issuer
GeneDx Holdings Corp.
CIK 0001818331
Entity typeother
Related Parties
1- filerCIK 0001873805
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:25 PM ET
- Size
- 7.6 KB